Your browser doesn't support javascript.
loading
RTS,S/AS02A Malaria Vaccine-Induced IgG Responses Equally Recognize Native-Like Fucosylated and Nonfucosylated Plasmodium falciparum Circumsporozoite Proteins.
Jairoce, Chenjerai; Macià, Dídac; Torres-Yaguana, Jorge P; Mayer, Leonie; Vidal, Marta; Santano, Rebeca; Hurtado-Guerrero, Ramón; Reiter, Karine; Narum, David L; Lopez-Gutierrez, Borja; Hamerly, Timothy; Sacarlal, Jahit; Aguilar, Ruth; Dinglasan, Rhoel R; Moncunill, Gemma; Izquierdo, Luis; Dobaño, Carlota.
Afiliación
  • Jairoce C; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Macià D; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
  • Torres-Yaguana JP; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Mayer L; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
  • Vidal M; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Santano R; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Hurtado-Guerrero R; Université Claude Bernard Lyon 1, Université de Lyon, Villeurbanne, France.
  • Reiter K; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Narum DL; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Lopez-Gutierrez B; Institute of Biocomputation and Physics of Complex Systems, University of Zaragoza, Zaragoza, Spain.
  • Hamerly T; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Sacarlal J; Fundación Agencia Aragonesa para la Investigación y el Desarrollo, Zaragoza, Spain.
  • Aguilar R; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Dinglasan RR; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Moncunill G; Emerging Pathogens Institute, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
  • Izquierdo L; Emerging Pathogens Institute, Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
  • Dobaño C; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
J Infect Dis ; 229(3): 795-799, 2024 Mar 14.
Article en En | MEDLINE | ID: mdl-37889513
ABSTRACT
The RTS,S/AS02A malaria vaccine is based on the Plasmodium falciparum circumsporozoite protein (PfCSP), which is O-fucosylated on the sporozoite surface. We determined whether RTS,S/AS02A-induced immunoglobulin G (IgG) antibodies recognize vaccine-like nonfucosylated PfCSP better than native-like fucosylated PfCSP. Similar to previous vaccine trials, RTS,S/AS02A vaccination induced high anti-PfCSP IgG levels associated with malaria protection. IgG recognition of nonfucosylated and fucosylated PfCSP was equivalent, suggesting that PfCSP fucosylation does not affect antibody recognition. Clinical Trials Registration. NCT00197041.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria Límite: Humans Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria Límite: Humans Idioma: En Revista: J Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: España